Yet Another Biogen’s Retinal Disease Gene Therapy Fails In Late-Stage Study
While basking in the glow of the approval for its Alzheimer’s treatment, Biogen Inc (NASDAQ:BIIB) announced that a gene therapy candidate…
Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up
It was "better late than never" for Novavax, Inc. (NASDAQ: NVAX), as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.
Karyopharm Therapeutics Posts Study Titled ‘Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma’ To ClinicalTrials.Gov Site
https://clinicaltrials.gov/ct2/show/NCT04925193
Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday
Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc.
Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression Patients
The FDA has signed off Lipocine Inc’s (NASDAQ:LPCN) Investigational New Drug Application (IND) to initiate a Phase 2 study to evaluate…
EyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology Indications
EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) has dosed the patient in Phase 2 proof-of-concept study evaluating its lead product candidate, PP-001, in patients…
RAPT Therapeutics Stock Soars As Atopic Dermatitis Candidate Shows Promising Action In Early-Stage Study
RAPT Therapeutics Inc (NASDAQ:RAPT) has announced topline results from its Phase 1b trial of RPT193 as monotherapy for moderate-to-severe atopic dermatitis…
Cocrystal’s Says Lead COVID-19 Antiviral CDI-45205 Shown To Be Active Against SARS-CoV-2 And 2 Prominent SARS-CoV-2 Variants
Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the